Reduction of Monocyte Chemoattractant Protein‐1 and Interleukin‐8 Levels by Ticlopidine in TNF‐α Stimulated Human Umbilical Vein Endothelial Cells
Authors:
Open Access
- 4 January 2009
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2009 (1) , 917837
Abstract
Atherosclerosis and its associated complications represent major causes of morbidity and mortality in the industrialized or Western countries. Monocyte chemoattractant protein‐1 (MCP‐1) is critical for the initiating and developing of atherosclerotic lesions. Interleukin‐8 (IL‐8), a CXC chemokine, stimulates neutrophil chemotaxis. Ticlopidine is one of the antiplatelet drugs used to prevent thrombus formation relevant to the pathophysiology of atherothrombosis. In this study, we found that ticlopidine dose‐dependently decreased the mRNA and protein levels of TNF‐α‐stimulated MCP‐1, IL‐8, and vascular cell adhesion molecule‐1 (VCAM‐1) in human umbilical vein endothelial cells (HUVECs). Ticlopidine declined U937 cells adhesion and chemotaxis as compared to TNF‐α stimulated alone. Furthermore, the inhibitory effects were neither due to decreased HUVEC viability, nor through NF‐kB inhibition. These results suggest that ticlopidine decreased TNF‐α induced MCP‐1, IL‐8, and VCAM‐1 levels in HUVECs, and monocyte adhesion. Therefore, the data provide additional therapeutic machinery of ticlopidine in treatment and prevention of atherosclerosis.Keywords
Funding Information
- National Science Council (NSC 96-2314-B-038-022, NSC 97-2314-038-004-MY3)
- National Science Council (NSC 96-2314-B-038-022, NSC 97-2314-038-004-MY3)
This publication has 63 references indexed in Scilit:
- Characterization of novel transforming growth factor-beta type I receptors found in malignant pleural effusion tumor cellsBMC Molecular Biology, 2007
- Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibilityBiochemical and Biophysical Research Communications, 2005
- IL-8 AND MCP-1 SECRETION IS ENHANCED BY THE PEPTIDE-NUCLEIC ACID IMMUNOMODULATOR, PRODUCT R, IN U937 CELLS AND PRIMARY HUMAN MONOCYTESCytokine, 2001
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- Platelet-derived Growth Factor Induction of the Immediate-early gene Is Mediated by NF-κB and a 90-kDa Phosphoprotein CoactivatorJournal of Biological Chemistry, 1996
- The Functional Role of the ELR Motif in CXC Chemokine-mediated AngiogenesisJournal of Biological Chemistry, 1995
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.Stroke, 1993
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKEThe Lancet, 1989